Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 2, 2015, Pages 174-181

  Bálint, Anita ^a   Farkas, Klaudia ^a   Éva, Pallagi Kunstár ^a   Terhes, Gabriella ^a   Urbán, Edit ^a   Szucs, Mónika ^a   Nyári, Tibor ^a   Bata, Zsuzsanna ^a   Nagy, Ferenc ^a   Szepes, Zoltán ^a   Miheller, Pál ^b   Lorinczy, Katalin ^b   Lakatos, Péter László ^b   Lovász, Barbara ^b   Tamás, Szamosi ^c   Kulcsár, Andrea ^d   Berényi, Anna ^a   Törocsik, Dalma ^a   Daróczi, Tímea ^a   Saródi, Zoltán ^a   Wittmann, Tibor ^a   Molnár, Tamás ^a   more..

^a UNIVERSITY OF SZEGED   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c Military Hospital   (Hungary)

^d Szent Laszlo Hospital   (Hungary)

Author keywords

Anti TNF therapy; Cellular immune response; Immunosuppression; Inflammatory bowel diseases; Influenza; Vaccination

Indexed keywords

ANTIBODY; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; INTERLEUKIN 2; SPLIT VIRION INFLUENZA VACCINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; WHOLE VIRION INFLUENZA VACCINE; IFNG PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; VIRUS ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BIOLOGICAL THERAPY; CELLULAR IMMUNITY; COHORT ANALYSIS; COMMON COLD; CONTROLLED STUDY; COUGHING; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN CELL; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; MYALGIA; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RELAPSE; RESPIRATORY FUNCTION DISORDER; SERUM; SHIVERING; SNEEZING; SORE THROAT; SWELLING; UPPER RESPIRATORY TRACT INFECTION; VERTIGO; BLOOD; CLINICAL TRIAL; HUMORAL IMMUNITY; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INFLUENZA, HUMAN; INFLUENZAVIRUS A; INFLUENZAVIRUS B; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VIRION;

ADULT; ANTIBODIES, VIRAL; BIOLOGICAL THERAPY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INFLUENZA VACCINES; INFLUENZA, HUMAN; INFLUENZAVIRUS A; INFLUENZAVIRUS B; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VIRION;

EID: 84921344346     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.928902     Document Type: Article

References (20)

1. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, et al. European evidence based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009;3:47-91.
2. Larubbia JR. Efficacy of the vaccination in inflammatory bowel disease. World J Gastroenterol 2013;19:1349-53.
3. Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:851-6.
4. Lu Y, Jacobson DL, Ashworth LA, Grand RJAL, McNeal MM, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009;104:444-53.
5. Andrisani G, Frasca D, Romero M, Armuzzi A, Felice C, Marzo M, et al. Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. J Crohns Colitis 2013;7:301-7.
6. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19:5-36.
7. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
8. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-9.
9. Ellebedy AH, Webby RJ. Influneza vaccines. Vaccine 2009;27:65-8.
10. Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, et al. Vaccinations in patients with immune mediated inflammatory diseases. Rheumatology 2010;49:1815-27.
11. Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006;101:1834-40.
12. Shale M, Czub M, Kaplan GG, Panaccione R, Ghosh S. Anti-tumor necrosis factor therapy and influenza: keeping it in perspective. Ther Adv Gastroenterol 2010;3:173-7.
13. deBruyn JC, Hilsden R, Fonseca K, Russell ML, Kaplan GG, Vanderkooi O, et al. Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:25-33.
14. Gelinck LBS, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, et al. The effect of anti-tumour necrosis factor a treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008;67:713-16.
15. Wu J, Liu SZ, Dong SS, Dong XP, Zhang WL, Lu M, et al. Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial. Vaccine 2010;28:6221-7.
16. Andrews NJ, Walker WT, Finn A, Heath PT, Collinson AC, Pollard AJ, et al. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Vaccine 2011;29:7913-19.
17. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, et al. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum 2009;60:2438-47.
18. Long CB, Ramos I, Rastogi D, Manwani D, Janow G, Del Rio M, et al. Humoral and cell-mediated immune responses to monovalent 2009 Influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children. J Pediatr 2012;160:74-81.
19. Ershler WB, Coe CL, Gravenstein S, Schultz KT, Klopp RG. IV. The correlation of in vitro and in vivo antibody response to influenza vaccine in rhesus monkeys. Clin Exp Immunol 1988;73:355-9.
20. Ershler WB, Moore AL, Socinski MA. Specific antibody synthesis in vitro. III. Correlation of in vivo and in vitro antibody response to influenza immunization in young and old subjects. J Clin Lab Immunol 1985;16:63-7.